Use of TFPI to treat severe bacterial infections

Details for Australian Patent Application No. 2006244053 (hide)

Owner Novartis AG

Inventors Hardy, Stephen F.; Dai, Yumin

Agent FB Rice

Pub. Number AU-A-2006244053

PCT Pub. Number WO2006/122139

Priority 60/678,465 06.05.05 US

Filing date 8 May 2006

Wipo publication date 16 November 2006

International Classifications

A61K 38/57 (2006.01) Medicinal preparations containing peptides

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/122139 Priority application(s): WO2006/122139

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244068-Modulators of indoleamine 2,3-dioxygenase and methods of using the same

2006244052-Improved swaging tool